Concentrix (NASDAQ:CNXC) Updates FY 2025 Earnings Guidance

Concentrix (NASDAQ:CNXC - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 11.530-11.760 for the period, compared to the consensus estimate of 11.530. The company issued revenue guidance of $9.7 billion-$9.8 billion, compared to the consensus revenue estimate of $9.6 billion. Concentrix also updated its Q3 2025 guidance to 2.800-2.910 EPS.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CNXC. Wall Street Zen downgraded shares of Concentrix from a "buy" rating to a "hold" rating in a report on Saturday, June 21st. Barrington Research restated an "outperform" rating and set a $54.00 price objective on shares of Concentrix in a report on Tuesday, June 24th. Robert W. Baird boosted their price objective on shares of Concentrix from $62.00 to $72.00 and gave the stock an "outperform" rating in a report on Thursday. Finally, Bank of America dropped their price objective on shares of Concentrix from $65.00 to $61.00 and set a "neutral" rating on the stock in a report on Friday. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $66.75.

Concentrix Price Performance

Shares of Concentrix stock traded down $3.42 during trading on Friday, hitting $51.71. 2,359,685 shares of the company's stock traded hands, compared to its average volume of 734,237. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.61 and a quick ratio of 1.65. The firm's fifty day moving average price is $53.86 and its 200 day moving average price is $49.54. Concentrix has a twelve month low of $36.28 and a twelve month high of $77.00. The company has a market cap of $3.30 billion, a PE ratio of 14.21, a PEG ratio of 0.67 and a beta of 0.56.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its earnings results on Thursday, June 26th. The company reported $2.70 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.06). Concentrix had a net margin of 2.54% and a return on equity of 16.31%. The business had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same quarter last year, the firm posted $2.69 earnings per share. Concentrix's revenue was up 1.5% on a year-over-year basis. Analysts forecast that Concentrix will post 10.11 earnings per share for the current year.

Concentrix Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 5th. Shareholders of record on Friday, July 25th will be given a $0.3328 dividend. The ex-dividend date is Friday, July 25th. This represents a $1.33 dividend on an annualized basis and a yield of 2.57%. Concentrix's dividend payout ratio (DPR) is presently 33.33%.

Insider Buying and Selling at Concentrix

In other Concentrix news, EVP Cormac J. Twomey sold 500 shares of the business's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $57.06, for a total value of $28,530.00. Following the transaction, the executive vice president now directly owns 38,130 shares in the company, valued at $2,175,697.80. The trade was a 1.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Olivier Duha sold 29,444 shares of the business's stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $48.52, for a total transaction of $1,428,622.88. Following the completion of the transaction, the director now owns 1,155,862 shares in the company, valued at approximately $56,082,424.24. This trade represents a 2.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 30,944 shares of company stock worth $1,510,158 over the last ninety days. Corporate insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On Concentrix

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. boosted its position in Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company's stock valued at $23,552,000 after buying an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company's stock valued at $8,152,000 after buying an additional 21,746 shares in the last quarter. Royal Bank of Canada boosted its position in Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company's stock valued at $2,643,000 after buying an additional 4,133 shares in the last quarter. Focus Partners Wealth acquired a new position in Concentrix in the first quarter valued at about $781,000. Finally, Geneos Wealth Management Inc. boosted its position in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after buying an additional 522 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors and hedge funds.

Concentrix Company Profile

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.